NYSE | ETF
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy.
It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index.
The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI).
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 4.36% |
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 4.19% |
| CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.98% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 3.74% |
| CBAY | Cymabay Therapeu | Healthcare | Biotechnology | 3.73% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 3.71% |
| LQDA | Liquidia Technologies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.28% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 2.81% |
| ELVN | Enliven Therapeutics Inc. | Healthcare | Biotechnology | 2.32% |
| AMRX | Amneal Pharmaceuticals, Inc. Class A Common Stock | Healthcare | Drug Manufacturers - Specialty & Generic | 2.27% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 2.25% |
| MBX | MBX Biosciences, Inc. Common Stock | Healthcare | Biotechnology | 2.24% |
| HRMY | Harmony Biosciences Holdings | Healthcare | Biotechnology | 2.16% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 2.09% |
| ESPR | Esperion Therapeutics Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.07% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.06% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.05% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 2.03% |
| TERN | Terns Pharmaceuticals Inc | Healthcare | Biotechnology | 2.03% |
| XERS | Xeris Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.02% |